Two Sigma Advisers’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-29,500
Closed -$21K 2986
2021
Q4
$21K Buy
29,500
+7,400
+33% +$5.99K ﹤0.01% 2546
2021
Q3
$20K Sell
22,100
-111,200
-83% -$134K ﹤0.01% 2402
2021
Q2
$221K Buy
133,300
+67,700
+103% +$113K ﹤0.01% 2245
2021
Q1
$137K Buy
+65,600
New +$136K ﹤0.01% 2409

Other funds holding MBII

Two Sigma Advisers's MBII Position: Q1 2022 in Review

Two Sigma Advisers sold out of Marrone Bio Innovations, Inc. (MBII) in Q1 2022, closing a stake of 29,500 shares — an estimated $21K sold.

Two Sigma Advisers first reported a position in MBII in Q1 2021 and held it in 4 quarters. The position peaked at $221K in Q2 2021. 71 funds tracked by Wall St. Rank hold MBII as of Q1 2022.

  • Two Sigma Advisers reported no remaining Marrone Bio Innovations, Inc. position as of Q1 2022 after selling out during the quarter.
  • Two Sigma Advisers sold 29,500 Marrone Bio Innovations, Inc. shares in Q1 2022, an estimated $21K.
  • Two Sigma Advisers first reported a position in Marrone Bio Innovations, Inc. in Q1 2021 and held it in 4 quarters.
  • Two Sigma Advisers's Marrone Bio Innovations, Inc. position peaked at $221K in Q2 2021.
  • 71 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q1 2022.

Based on Two Sigma Advisers's 13F filing for Q1 2022, filed 16 May 2022.